GLSI Competitors & Alternatives
Compare Greenwich Lifesciences Inc with similar stocks in the same industry
Biotechnology
GLSI
Main Stock$18.57
Tradestie Score
50
Market Cap
$137.80M
Analyst Upside
+155.8%
Top Competitors
234 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
EDIT
Editas Medicine, Inc. Common Stock
|
$3.16
|
$319.22M | - | 56 | Compare |
|
CTNM
Contineum Therapeutics, Inc. Class A Common Stock
|
$14.62
|
$308.74M | - | 60 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$9.64
|
$304.12M | - | 57 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$21.30
|
$297.23M | - | 59 | Compare |
|
TECX
Tectonic Therapeutic, Inc. Common Stock
|
$34.34
|
$293.03M | - | 60 | Compare |
|
OMER
Omeros Corporation
|
$10.01
|
$281.75M | 9.0 | 58 | Compare |
|
DBVT
DBV Technologies S.A.
|
$15.98
|
$275.54M | - | 57 | Compare |
|
ALLO
Allogene Therapeutics, Inc. Common Stock
|
$1.93
|
$275.13M | - | 44 | Compare |
|
VOR
Vor Biopharma Inc. Common Stock
|
$18.03
|
$269.08M | - | 59 | Compare |
|
IMMP
Immutep Limited American Depositary Shares
|
$0.45
|
$265.68M | - | 53 | Compare |
More GLSI Analysis
Data updated: Jul 14, 2026 | Industry: Biotechnology (SIC 2834)
234 stocks in this industry